scandenoside R1
114715-44-5
|
Notoginsenoside R3
87741-76-2
|
Vinaginsenoside R3
156012-92-9
|
LONG R3 IGF-I RECOMBINANT ANALOG
143045-27-6
|
(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-carboxybutanoyl]amino]propanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpr
101849-76-7
|
Oxiranecarboxamide, 3-methyl-2-propyl-, (2R-cis)- (9CI)
200356-08-7
|
Oxiranecarboxamide, 3-methyl-2-(1-methylethyl)-, (2R,3R)- (9CI)
200356-10-1
|
R3 IGF-I
139659-92-0
|
1-(2-Bromo-5-fluorophenyl)but-3-en-1-one
1394141-12-8
|
5-amino-2-[(2,6-difluorophenyl)carbonyl]-1,2-oxazol-3(2H)-one
1807977-38-3
|
6,6'-(piperazine-1,4-diyldimethanediyl)bis(2,3-dihydro-1H,5H-pyrido[3,2,1-ij]quinolin-5-one)
1807979-88-9
|
N-(3-aminobenzyl)[1,2,4]triazolo[4,3-b]pyridazin-6-amine
1807979-92-5
|
3,3'-(piperazine-1,4-diyldimethanediyl)bis(1-ethylquinolin-2(1H)-one)
1807982-48-4
|
2-(3-chloro-1H-1,2,4-triazol-1-yl)pyridine-4-carbonitrile
1807982-63-3
|
5-amino-2-[(2,5-difluorophenyl)carbonyl]-1,2-oxazol-3(2H)-one
1807982-64-4
|
5-amino-2-{[4-(trifluoromethoxy)phenyl]carbonyl}-1,2-oxazol-3(2H)-one
1807977-19-0
|
Methyl 2-chloro-3-cyano-6-phenylpyridine-4-carboxylate
1807988-29-9
|
N-(2,5-dibromopyridin-3-yl)-3-(trifluoromethyl)benzenesulfonamide
1799545-18-8
|
